Particle Sciences Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Particle Sciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014178
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Particle Sciences Inc (Particle Sciences), a subsidiary of The Lubrizol Corp is a contract research organization that offers complete formulation, analytic, bioanalytic and clinical trial material manufacturing solutions. The organization concentrates on BCS II/III/IV molecules, biologics and highly potent compounds through a variety of technologies including gels, emulsions, drug or device combination products, micro and nano-particulates, and solid solutions, among others. Particle Sciences serves clients including privately-backed start-ups, foundations, governments, universities, hospitals and pharmaceutical and biotech companies. The organization also has proprietary drug delivery platforms for the preformulation and formulation of drugs as well as technology platform for drug combination. Particle Sciences is headquartered in Bethlehem, Pennsylvania, the US.

Particle Sciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Particle Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Particle Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Particle Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Particle Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Particle Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9
Particle Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Particle Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Particle Sciences Enters Into Licensing Agreement With Lyotropic Therapeutics For Drug Delivery Technology 11
Particle Sciences Enters Into Co-Development Agreement With Actavis 12
Particle Sciences Enters Into Co-Development Agreement With Pernix Therapeutics 13
Particle Sciences Enters Into An Agreement With Absorption Systems 14
Hovione Enters Into Co-Development Agreement With Particle Sciences 15
Licensing Agreements 16
Glenmark Pharma Enters into Licensing Agreement with Particle Sciences 16
Acquisition 17
Lubrizol Acquires Particle Sciences 17
Particle Sciences Inc – Key Competitors 18
Particle Sciences Inc – Key Employees 19
Particle Sciences Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Other Significant Developments 21
May 31, 2016: Particle Sciences, a part of Lubrizol LifeSciences, Adds Sterile Powder Filling and Capsule Filling Capabilities 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Particle Sciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Particle Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Particle Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Particle Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Particle Sciences Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Particle Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9
Particle Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Particle Sciences Enters Into Licensing Agreement With Lyotropic Therapeutics For Drug Delivery Technology 11
Particle Sciences Enters Into Co-Development Agreement With Actavis 12
Particle Sciences Enters Into Co-Development Agreement With Pernix Therapeutics 13
Particle Sciences Enters Into An Agreement With Absorption Systems 14
Hovione Enters Into Co-Development Agreement With Particle Sciences 15
Glenmark Pharma Enters into Licensing Agreement with Particle Sciences 16
Lubrizol Acquires Particle Sciences 17
Particle Sciences Inc, Key Competitors 18
Particle Sciences Inc, Key Employees 19

★海外企業調査レポート[Particle Sciences Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Epax Norway AS:企業の戦略・SWOT・財務情報
    Epax Norway AS - Strategy, SWOT and Corporate Finance Report Summary Epax Norway AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Sysmex Corp (6869):医療機器:M&Aディール及び事業提携情報
    Summary Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory inform …
  • Sumitomo Dainippon Pharma Co., Ltd.:企業の戦略・SWOT・財務分析
    Sumitomo Dainippon Pharma Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Dainippon Pharma Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Lumenis Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Lumenis Ltd (Lumenis), a subsidiary of XIO Group, is an energy-based medical device company for aesthetic, surgical and ophthalmic applications in the field of minimally invasive clinical solutions. It manufactures and distributes medical and aesthetic lasers and light-based systems. Its maj …
  • Crown Point Energy Inc (CWV):石油・ガス:M&Aディール及び事業提携情報
    Summary Crown Point Energy Inc (Crown Point), formerly Crown Point Ventures is an oil and gas company that offers oil and gas development and exploration services. The company acquires and produces crude oil and natural gas deposits. It holds interests in Cerro de Los Leones exploration concessions …
  • Eiken Chemical Co Ltd (4549):企業の製品パイプライン分析2018
    Summary Eiken Chemical Co Ltd (Eiken Chemical), a subsidiary of Hitachi High-Technologies Corp is a medical equipment provider that offers molecular genetic products and medical devices. The company manufactures and markets clinical diagnostics and equipment, among others. It also provides fecal imm …
  • NetSol Technologies, Inc. (NTWK):企業の財務・戦略的SWOT分析
    NetSol Technologies, Inc. (NTWK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • LycoRed Ltd:戦略・SWOT・企業財務分析
    LycoRed Ltd - Strategy, SWOT and Corporate Finance Report Summary LycoRed Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Summit Midstream Partners LP (SMLP):企業の財務・戦略的SWOT分析
    Summary Summit Midstream Partners LP (SMLP) is an oil and gas company that develops, owns and operates midstream energy infrastructure assets located in unconventional shale resource basins and shale formations across North America. The company operates natural gas, crude oil, and produced water gat …
  • BWX Technologies Inc (BWXT):電力:M&Aディール及び事業提携情報
    Summary BWX Technologies Inc (BWXT) is a specialty manufacturer of nuclear components. It designs, engineers, and manufactures precision naval nuclear components, reactors, and nuclear fuel for the US Government. The company also provides special nuclear materials processing and environmental site r …
  • I.Ceram SA (ALICR):医療機器:M&Aディール及び事業提携情報
    Summary I.Ceram SA (I.Ceram) is a medical equipment and device company that designs, manufactures, and markets joint implants for neurosurgery and other surgical procedures. The company’s products include bone fillers, alumina bio-ceramic implants, trepan caps, cervical plates and blocks for cervica …
  • Aviragen Therapeutics Inc (AVIR):企業の財務・戦略的SWOT分析
    Aviragen Therapeutics Inc (AVIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • TECSYS Inc. (TCS):企業の財務・戦略的SWOT分析
    TECSYS Inc. (TCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Edison SpA:企業の発電所・SWOT分析2018
    Edison SpA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …
  • IMI plc:企業の戦略・SWOT・財務情報
    IMI plc - Strategy, SWOT and Corporate Finance Report Summary IMI plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Vivus Inc (VVUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Vivus Inc (Vivus) is a biopharmaceutical company which develops and commercializes next-generation therapeutics for addressing unmet needs in obesity, sleep apnea, diabetes and sexual health. The company's marketed products include, Qsymia (phentermine and topiramate extended-release), indic …
  • Adama Ltd (000553):企業の財務・戦略的SWOT分析
    Adama Ltd (000553) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Experian plc:企業の戦略・SWOT・財務分析
    Experian plc - Strategy, SWOT and Corporate Finance Report Summary Experian plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Petroleos de Venezuela SA:企業の戦略的SWOT分析
    Petroleos de Venezuela SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Moog Inc.:企業のM&A・事業提携・投資動向
    Moog Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Moog Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆